IQVIA Holdings | IQV - Betriebsaufwand

Aktienkurs
162.28
Täglich Wechseln
1.60 1.00%
Monatlich
-2.03%
Jährlich
7.99%
Q2 Prognose
172.58




Betriebsaufwand Veränderung Datum
Accenture USD 15.55B 10.37M 2025-12
Agilent USD 1.44B 27M 2025-12
Bruker USD 900.9M 124.3M 2025-12
Cardinal Health USD -2.88B 5M 2025-12
Celltrion KRW 724.99B 6B 2025-09
Charles River Laboratories USD 918.41M 2.49B 2025-12
Cigna USD 41.71B 92.12M 2025-12
Cognizant Technology Solutions USD 4.48B 10.42B 2025-12
Computer Programs Systems USD 207.2M 119.28M 2025-12
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
CVS Health USD 103.58B 3.66B 2025-12
Danaher USD 52.95B 47.61B 2026-03
Dentsply International USD 423M 1.06B 2025-12
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Divis Laboratories Ltd INR 18.32B 1.08B 2025-12
Elevance Health USD 43.9B 5.26B 2026-03
Humana USD 33.32B 1.07B 2025-12
IBM USD 32.97B 17.54B 2026-03
Illumina USD 903M 69M 2025-12
Infosys INR 370.7B 366.69B 2025-12
Kangmei Pharma CNY 1.39B 144.29M 2025-09
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Laboratory Of America USD 3.13B 32.4M 2025-12
Malin Corporation EUR 1.1M 400K 2024-12
McKesson USD 104.5B 2.85B 2025-12
Mettler Toledo International USD 777.8M 42.3M 2025-12
Organigram Holdings CAD 83.66M 24.44M 2025-12
Ovoca Bio EUR 1.16M 4.48M 2025-06
Pharma Mar EUR 46.87M 7.24M 2025-12
Publicis EUR 7.53B 244M 2025-12
Qiagen NV USD 418.54M 23.25M 2025-12
Quest Diagnostics USD 2.5B 76M 2026-03
Revvity USD 626.22M 25.62M 2025-12
Sartorius EUR 738.4M 22.4M 2026-03
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Tilray USD 237.52M 17.34M 2025-09
UnitedHealth USD 102.68B 7.27B 2026-03
Veeva Systems USD 590.07M 19.69M 2025-12
Veradigm USD 188M 61.08M 2022-12
Waters USD 661.85M 1.67B 2025-12
Zealand Pharma A/S 775.97M 265.08M 2025-12
Zz Pientze Pharmaceu CNY 1.55B 129.66M 2025-09